tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Vamil Divan, 259 are a BUY (66.07%), 120 are a HOLD (30.61%), 13 are a SELL (3.32%).
Analyst Vamil Divan, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 65.15% that have a potential upside of 33.6% achieved within 270 days.
Vamil Divan’s has documented 792 price targets and ratings displayed on 48 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AMGN, Amgen at 06-Feb-2026.
Analyst best performing recommendations are on ARAV (ARAVIVE).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 8/9/2022. The price target of $276 was fulfilled within 3 days with a profit of $47.55 (20.81%) receiving and performance score of 69.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Feb-2026
$260
$40.32 (18.35%)
$220
20 days ago
(25-Feb-2026)
5/6 (83.33%)
$31.56 (13.82%)
168
Hold Since 07-Jan-2026
$230
$10.32 (4.70%)
$240
1 months 12 days ago
(05-Feb-2026)
1/2 (50%)
$10.98 (5.01%)
8
Buy Since 24-Jan-2022
$270
$50.32 (22.91%)
$269
1 months 12 days ago
(05-Feb-2026)
16/20 (80%)
$50.98 (23.28%)
510
Hold Since 14-May-2025
$230
$10.32 (4.70%)
$235
1 months 18 days ago
(27-Jan-2026)
17/18 (94.44%)
$6.07 (2.71%)
279
Buy Since 16-Oct-2020
$260
$40.32 (18.35%)
$235
4 months 14 days ago
(03-Nov-2025)
15/16 (93.75%)
$49.73 (23.65%)
463
Which stock is Vamil Divan is most bullish on?
Which stock is Vamil Divan is most reserved on?
What Year was the first public recommendation made by Vamil Divan?
